我们报告了通过芳基硼亲核试剂与丙二酸衍生物偶联的脱羧羰基α-芳基化。这个过程是通过有氧氧化铜催化与脱羧烯醇化物拦截的结合来实现的,这让人联想到聚酮化合物生物合成中的丙二酰辅酶 A 反应性。该方法能够合成含有与现有α-芳基化反应范式不相容的亲电官能团的乙酸单芳基酯衍生物。该反应的效用在药物中间体合成和后期功能化中得到了证明。
We have developed a high-efficiency and practical Cu-catalyzed cross-coupling to directly construct versatile α-aryl-esters by utilizing readily available aryl bromides (or chlorides) and malonates. These gram-scale approaches occur with turnovers of up to 1560 and are smoothly conducted by the usage of a low catalyst loading, a new available ligand, and a green solvent. A variety of functional groups
Water greatly restrained the formation of self-coupling of boronicacids in a palladium-catalyzed cross-coupling reaction between boronicacids and ethyl bromoacetate with an aminophosphine ligand; good to excellent yields of cross-coupling product were obtained.
OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS
申请人:The Governors of the University of Alberta
公开号:US20180186721A1
公开(公告)日:2018-07-05
Described herein are methods of oxidative coupling of aryl boron reagents with sp
3
-carbon nucleophiles, and ambient decarboxylative arylation of malonate half-esters via oxidative catalysis.
Tetrahydropyridinyl and dihydropyrrolyl compounds and the use thereof
申请人:Purdue Pharma L.P.
公开号:US08324249B2
公开(公告)日:2012-12-04
The invention relates to tetrahydropyridinyl and dihydropyrrolyl compounds of Formula (I): and pharmaceutically acceptable salts, prodrugs, or solvates thereof, wherein X, Y, Z, R1, R2, m, and n are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of calcium channels, and particularly N-type calcium channels. Compounds of the present invention are especially useful for treating pain.
Control of the regioselectivity of nucleophiles toward alkylating agents is a fundamental problem in heterocyclic chemistry. Substrate-controlled TfOH-catalyzed alkylation of 4-hydroxycoumarin with diazo compounds has been developed to provide rapid access to the C3- or O-alkylated 4-hydroxycoumarins with high efficiency. The regioselectivity can be determined by varying the electronic nature of the